Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 7 Results

Title
Intervention Indication Therapeutic Area Year Actions
Imetelstat for Myelodysplastic syndrome Imetelstat (GRN163L; JNJ-63935937) Myelodysplastic syndrome (MDS) Haematological Cancer and Lymphomas 2020 View  |  Download
Magrolimab in addition to azacitidine for myelodysplastic syndromes - First-line Azacitidine (Vidaza; CC-486) , Magrolimab (Hu5F9-G4) Myelodysplastic syndrome (MDS) Haematological Cancer and Lymphomas 2021 View  |  Download
Pevonedistat in addition to azacitidine for Higher-Risk Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia and Low Blast Acute Myeloid Leukemia – first-line Azacitidine (Vidaza; CC-486) , Pevonedistat (MLN-4924; TAK-924) Acute myeloid leukaemia (AML) , Chronic myelomonocytic leukaemia (CMML) , Myelodysplastic syndrome (MDS) Haematological Cancer and Lymphomas 2020 View  |  Download
Rigosertib for myelodysplastic syndrome - second line Rigosertib (Estybon; ON-01910.Na) Myelodysplastic syndrome (MDS) Haematological Cancer and Lymphomas 2020 View  |  Download
Sabatolimab in addition to azacitidine for myelodysplastic syndromes – first-line Azacitidine (Vidaza; CC-486) , Sabatolimab (MBG453) Chronic myelomonocytic leukaemia (CMML) , Myelodysplastic syndrome (MDS) Haematological Cancer and Lymphomas 2021 View  |  Download
Treosulfan in combination with Fludarabine for Malignant and Non-Malignant diseases - prior to stem cell transplantation Fludarabine (fludarabine phosphate) , Treosulfan (Ovastat) Acute myeloid leukaemia (AML) , Myelodysplastic syndrome (MDS) Haematological Cancer and Lymphomas 2018 View  |  Download
Venetoclax in combination with azacitidine for myelodysplastic syndrome Azacitidine (Vidaza; CC-486) , Venetoclax (Venclyxto; ABT-199; Venclexta; GDC-0199) Myelodysplastic syndrome (MDS) Haematological Cancer and Lymphomas 2023 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications